Y Intercept Hong Kong Ltd bought a new stake in Proto Labs, Inc. (NYSE:PRLB – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm bought 42,182 shares of the industrial products company’s stock, valued at approximately $1,689,000.
Several other hedge funds and other institutional investors also recently made changes to their positions in PRLB. NewEdge Advisors LLC boosted its position in shares of Proto Labs by 7,380.0% during the 1st quarter. NewEdge Advisors LLC now owns 748 shares of the industrial products company’s stock worth $26,000 after acquiring an additional 738 shares in the last quarter. GAMMA Investing LLC raised its position in Proto Labs by 249.4% during the first quarter. GAMMA Investing LLC now owns 926 shares of the industrial products company’s stock valued at $32,000 after purchasing an additional 661 shares in the last quarter. CWM LLC lifted its stake in Proto Labs by 50.4% during the first quarter. CWM LLC now owns 1,840 shares of the industrial products company’s stock worth $64,000 after purchasing an additional 617 shares during the last quarter. PNC Financial Services Group Inc. boosted its holdings in shares of Proto Labs by 14.1% in the 1st quarter. PNC Financial Services Group Inc. now owns 2,165 shares of the industrial products company’s stock valued at $76,000 after purchasing an additional 267 shares in the last quarter. Finally, State of Wyoming bought a new position in shares of Proto Labs in the 1st quarter valued at $99,000. 84.54% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several analysts recently weighed in on the company. Craig Hallum upgraded Proto Labs from a “hold” rating to a “buy” rating and set a $54.00 price objective for the company in a research report on Friday, August 1st. Cantor Fitzgerald raised their price target on shares of Proto Labs from $50.00 to $51.00 and gave the company an “overweight” rating in a research note on Friday, August 1st. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Proto Labs in a report on Wednesday, October 8th. Finally, Wall Street Zen raised shares of Proto Labs from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 2nd. Two equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $52.50.
Proto Labs Price Performance
NYSE:PRLB opened at $49.69 on Friday. Proto Labs, Inc. has a one year low of $27.18 and a one year high of $55.90. The company has a market cap of $1.19 billion, a PE ratio of 82.82 and a beta of 1.24. The firm’s 50 day simple moving average is $50.88 and its 200 day simple moving average is $43.81.
Proto Labs (NYSE:PRLB – Get Free Report) last issued its quarterly earnings results on Friday, October 31st. The industrial products company reported $0.47 EPS for the quarter, topping analysts’ consensus estimates of $0.39 by $0.08. Proto Labs had a net margin of 2.91% and a return on equity of 2.22%. The company had revenue of $135.37 million for the quarter, compared to analyst estimates of $133.83 million. During the same quarter in the previous year, the business earned $0.47 earnings per share. Proto Labs’s revenue was up 8.0% compared to the same quarter last year. Proto Labs has set its Q4 2025 guidance at 0.300-0.380 EPS. Equities research analysts expect that Proto Labs, Inc. will post 0.81 EPS for the current year.
Insider Activity
In related news, CEO Suresh Krishna acquired 1,725 shares of the business’s stock in a transaction that occurred on Monday, August 4th. The shares were bought at an average cost of $43.51 per share, with a total value of $75,054.75. Following the completion of the purchase, the chief executive officer directly owned 18,021 shares in the company, valued at $784,093.71. The trade was a 10.59% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this link. 1.70% of the stock is owned by company insiders.
Proto Labs Company Profile
Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.
See Also
- Five stocks we like better than Proto Labs
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Is Beyond Meat a Buy After Meme Stock Surge? Analysts Say No
- Are Penny Stocks a Good Fit for Your Portfolio?
- ABBV Stock: $250 May Be the New Floor After Big Q3 Earnings Beat
- 10 Best Airline Stocks to Buy
- Super Micro’s Moment of Truth: A Growth Story Under Pressure
Want to see what other hedge funds are holding PRLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Proto Labs, Inc. (NYSE:PRLB – Free Report).
Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.
